Concepedia

Carla Valenzuela Ripoll

CV

4

Publications

200

Citations

4

H-Index

2022

Active since

Affiliations

Washington University in St. Louis(Current)

John Cochran VA Medical Center

Harvard University

Carla Valenzuela Ripoll is an author at Washington University in St. Louis specializing in cardiovascular pharmacology, physiology, and cell biology.

ORCID

Top concepts

Publications per year

2022–2023

4

Publications

4

Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity

Mualla Özcan, Zhen Guo, Carla Valenzuela Ripoll et al. · Cell Metabolism · 2023 · 80 citations · Full text

, , +16

Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy

Rimpy Dhingra, Inna Rabinovich-Nikitin, Sonny Rothman et al. · Circulation · 2022 · 76 citations · Full text

Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury

Zhen Guo, Carla Valenzuela Ripoll, Antonino Picataggi et al. · JACC Basic to Translational Science · 2023 · 33 citations · Full text

JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit

Zhen Guo, Yuehuai Hu, Guoshuai Feng et al. · Acta Pharmacologica Sinica · 2023 · 11 citations · Full text

, , +11

Rows per page

1–4 of 4